Delivery Order 36F79724D0185-36C25925F0058
Award Date
10/24/24
Potential Completion Date
10/29/24
Potential Value
$21K
Federal Agency
Veterans Integrated Service Network 19
Awardee
Amicus Therapeutics US, LLC
Ultimate Awardee
Amicus Therapeutics, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Amicus Therapeutics US, LLC, a subsidiary of the publicly traded biopharmaceutical company Amicus Therapeutics, Inc. The contract is for the delivery of the specialty medication Galafold (migalastat), an approved enzyme replacement therapy used to treat Fabry disease, to VHA facilities and service networks nationwide. The contract is issued under the...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Amicus Therapeutics US, LLC, a subsidiary of publicly traded biopharmaceutical company Amicus Therapeutics, Inc. The order is for the delivery of the specialty medication Galafold (migalastat) to VHA facilities and service networks under the General Services Administration's Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule. The delivery order has a...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is for the supply of the drug Galafold (migalastat), used to treat Fabry disease, to VHA facilities and networks across the country. The contract was awarded under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract, which provides a mechanism for...
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc., under the General Services Administration's (GSA) Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract. The delivery order is for the emergency pharmaceutical Galafold (migalastat) 123mg, an FDA-approved enzyme replacement therapy used to treat Fabry disease, a rare genetic disorder. The delivery order has a ceiling value of...
This is a firm fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a pharmaceutical company focused on rare genetic diseases. The contract is for the supply of the drug Galafold 123 mg, an enzyme replacement therapy used to treat Fabry disease. The contract, valued at $21,891.21, is a task order under the VA's Federal Supply Schedule (FSS) contract 36F79724D0185 for Pharmaceuticals and Drugs (FSS-61-IB), which has a total...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is for the emergency procurement of migalastat (Galafold), a drug used to treat Fabry disease, a rare genetic disorder. The delivery order, valued at $21,089.47, was placed against Amicus Therapeutics US, LLC's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract administered by the General...
This federal contract award is for the delivery of GALAFOLD 123 MG to the Department of Veterans Affairs (VA). The contract was awarded to Amicus Therapeutics US, LLC, a subsidiary of the biopharmaceutical company Amicus Therapeutics, Inc. The $21,089.47 firm fixed price delivery order has a completion date of November 19, 2024 and was awarded on November 14, 2024. Amicus Therapeutics US, LLC holds a Federal Supply Schedule (FSS) contract (36F79724D0185) with the VA's Pharmaceuticals and Drugs...
The U.S. Department of Veterans Affairs (VA) awarded a $21,089.47 firm fixed price delivery order contract to Amicus Therapeutics US, LLC, a subsidiary of Amicus Therapeutics, Inc. The contract is for the supply of GALAFOLD 123 MG, an enzyme replacement therapy for the treatment of Fabry disease. This delivery order was placed under Amicus Therapeutics US, LLC's Federal Supply Schedule (FSS) contract 36F79724D0185, which has a ceiling value of $13,024,630 and a period of performance through...
This federal contract award is for the delivery of the pharmaceutical product Galafold (migalastat) 123 mg to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5). The $21,089.47 firm-fixed-price delivery order was awarded to Amicus Therapeutics US, LLC, a subsidiary of the parent company Amicus Therapeutics, Inc. Amicus Therapeutics US, LLC holds a Federal Supply Schedule (FSS) contract with the VA to supply specialized medications like Galafold, which is...
This federal contract award (ID: 36F79724D0185|36C24925N0624) was issued by the Department of Veterans Affairs (VA) to Amicus Therapeutics US, LLC, a biopharmaceutical company focused on rare genetic diseases. The $65,673.63 firm fixed-price delivery order is for the pharmaceutical product Galafold (migalastat) 123 mg, an enzyme replacement therapy used to treat Fabry disease. The award is part of Amicus Therapeutics US, LLC's $13,024,630 Federal Supply Schedule (FSS) contract (36F79724D0185)...